Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III, Prospective, Multicenter, Single-blind, Randomized, Superiority to Evaluate the Efficacy and Safety of Methenamine Association 250mg + Methylthioninium Chloride 20 mg Compared to Phenazopyridine 100 mg in Symptomatic Control of Dysuria

NCT01657448 is registered in ClinicalTrials.gov with EMS as lead sponsor.

NCT NCT01657448
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01657448 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III, Prospective, Multicenter, Single-blind, Randomized, Superiority to Evaluate the Efficacy and Safety of Methenamine Association 250mg + Methylthioninium Chloride 20 mg Compared to Phenazopyridine 100 mg in Symptomatic Control of Dysuria
Lead sponsor
EMS
Phase
Phase 3
Overall status
Completed
Start date
June 27, 2016
Completion date
December 22, 2017
Enrollment
316 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

dysuria